This topic contains a solution. Click here to go to the answer

Author Question: Degeneration of neurons within the ________ results in loss of ________ function and Huntington's ... (Read 51 times)

eruditmonkey@yahoo.com

  • Hero Member
  • *****
  • Posts: 546
Degeneration of neurons within the ________ results in loss of ________ function and Huntington's disease.
 
  a. caudate and putamen; GABAergic
  b. globus pallidus; dopaminergic
  c. frontal cortex; cholinergic
  d. pons; GABAergic
  e. nigrostriatal bundle; dopamine

Question 2

The hyperdirect pathway involves excitatory input from the ________ that rapidly inhibits motor behavior.
 
  a. amygdala
  b. pre-SMA
  c. parietal cortex
  d. globus pallidus
  e. primary motor cortex



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cswans24

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

Answer: a. caudate and putamen; GABAergic

Answer to Question 2

Answer: b: pre-SMA





 

Did you know?

Anti-aging claims should not ever be believed. There is no supplement, medication, or any other substance that has been proven to slow or stop the aging process.

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library